A decision guide for upgrading through the retinoid ladder - from OTC retinol to tazarotene - mapped to the skin-aesthetic levers that actually matter: collagen, texture, oil, and pigmentation.
Most people stall on the wrong rung of the retinoid ladder. They white-knuckle 0.5% retinol for two years expecting tretinoin-tier remodeling, or they jump straight to tazarotene and spend six weeks looking like a peeled tomato. The four mainstream options - retinol, adapalene, tretinoin, tazarotene - are not interchangeable. Each one hits a different point on the potency/tolerability curve, and each one is the correct answer for a specific skin goal at a specific stage. This is the upgrade map.
All retinoids eventually become retinoic acid (or bind RAR directly) and drive the same downstream program: increased epidermal turnover, suppressed sebum, normalized keratinization, and - over months - measurable dermal collagen synthesis. The differences are potency, receptor selectivity, and irritation profile.
| Retinoid | Relative potency | Receptor profile | Best lever |
|---|---|---|---|
| Retinol (OTC) | ~1x baseline | Converts to RA in 2 steps | Maintenance, beginners, thin skin |
| Adapalene 0.1-0.3% | ~tret-equivalent for acne | RAR-beta/gamma selective | Acne, oil control, sensitive skin |
| Tretinoin 0.025-0.1% | High | Pan-RAR | Photoaging, collagen, texture |
| Tazarotene 0.05-0.1% | Highest | RAR-beta/gamma selective | Deep wrinkles, stubborn texture, PIH |
A 2022 systematic review of topical tretinoin across concentrations from 0.025% to 5% and durations of 3-24 months found efficacy across the board for photoaging endpoints - meaning the lowest-strength tret formulation is already doing real work, and the upgrade question is about tolerability and rate of return, not whether the lower rungs "work."
OTC retinol at 0.3-1% is the right starting point for anyone whose barrier is fragile, anyone under 25 with no specific complaint, or anyone who needs to build tolerance before stepping up. It is also a legitimate maintenance tool once a tret/taz course has done the heavy lifting.
What retinol is not good for: anyone chasing visible photoaging reversal on a 6-12 month timeline. The conversion losses (retinol -> retinaldehyde -> retinoic acid) mean the active dose at the receptor is a fraction of what an equivalent gram of tretinoin delivers. Stay here longer than 6-9 months without escalation and the law of diminishing returns kicks in hard.
Upgrade trigger: tolerating nightly retinol with zero flaking, zero redness, and no further visible improvement for 8+ weeks.
Adapalene 0.1% (now OTC in the US as Differin) and 0.3% (Rx) is the cleanest answer for acne-dominant skin. It is RAR-beta/gamma selective, photostable, and notably less irritating than tretinoin at comparable acne efficacy. The looksmaxxing case for adapalene:
Where adapalene is the wrong choice: pure anti-aging goals on non-acneic skin. The receptor selectivity that makes it gentle on the barrier also means less of the pan-RAR collagen-remodeling signal that tretinoin and tazarotene deliver.
Upgrade trigger: acne controlled, oil normalized, but texture, fine lines, or post-inflammatory pigmentation are now the bottleneck.
This is the rung most physique-focused and aesthetics-focused users should plan to spend years on. Tretinoin 0.025% is the standard entry; 0.05% is the most-studied concentration for photoaging; 0.1% is for tolerant skin chasing maximum remodeling. Documented effects across the tretinoin literature include reduced fine wrinkles, improved dyspigmentation, smoother texture, and measurable increases in dermal collagen on biopsy at 6-12 months.
Protocol notes that the community has settled on:
"For thin skin, I suggest you try Skin Actives Collagen serum. Tretinoin can help with cell regeneration too!" - r/SkincareAddiction veteran user thread
Microneedling stacks well with tretinoin between sessions - pause topical retinoid 3-5 days before and after a 1.0-1.5mm stamp. Topical GHK-Cu is also a clean partner on alternate nights once tolerance is built.
Upgrade trigger: plateaued on 0.05-0.1% tretinoin nightly with full tolerance, and the remaining complaint is deep texture, stubborn melasma, or coarse wrinkling that hasn't budged in 6+ months.
Tazarotene 0.1% is the most potent topical retinoid in routine cosmetic use. Head-to-head trials against tretinoin 0.05% generally show tazarotene edging it for fine-wrinkle reduction and pigmentation endpoints, at the cost of more irritation. The 0.05% formulation is the gentler entry point and is often where users land long-term.
Who actually needs to go here:
Tazarotene is also teratogenic (pregnancy category X historically) - this is a hard contraindication for anyone pregnant or planning pregnancy. Tretinoin and adapalene carry warnings; tazarotene carries the strongest one. Do not blur this.
The ladder is a decision tree, not a linear march. Map the dominant complaint to the right rung:
Two non-negotiable adjuncts at every rung: daily SPF (the entire collagen thesis collapses without it) and a bland, ceramide-forward moisturizer to keep the barrier intact while the retinoid works. Niacinamide 4-5% layers cleanly with all four and helps with the redness phase.
Pick the rung that matches the actual complaint, give it 12 weeks before judging, and only escalate when tolerance is full and progress has stalled. Most users belong on tretinoin 0.05% for years, not on a parade of new actives every quarter. The compounding interest on a single well-run retinoid is the highest-ROI move in skinmaxxing - everything else (peptides, microneedling, lasers) is an accelerant on top of that base.
Powered by BTST